Skip to content
Skip to content
The Mental Wealth Hub

The Edit

Sources & Key Research — The Psychedelic Renaissance

  1. 1. Therapeutic Goods Administration. Psilocybin and MDMA rescheduled to enable prescribing by authorised psychiatrists. Media release, 2023. Link
  2. 2. Mitchell JM et al. MDMA-assisted therapy for severe PTSD: a randomised, double-blind, placebo-controlled phase 3 study. Nature Medicine, 2021;27(6):1025–1033. Link
  3. 3. Carhart-Harris RL et al. Trial of psilocybin versus escitalopram for depression. New England Journal of Medicine, 2021;384(15):1402–1411. Link
  4. 4. Polito V, Stevenson RJ. A systematic study of microdosing psychedelics. PLoS ONE, 2019;14(2):e0211023. Link
  5. 5. Nutt D, Carhart-Harris R. The current status of psychedelics in psychiatry. JAMA Psychiatry, 2021;78(2):121–127. Link
← Back to The Psychedelic Renaissance

Not sure where to begin?

You don’t need to have it all figured out. Start with how you’re feeling, and we’ll help you find your way to tools, stories and support.

Start Here